Circulating tumour cells in locally advanced breast cancer

Clinical and Translational Oncology

Volumn 11, Issue 8, 2009, Pages 544-547

  García Sáenz, José Ángel ^a   Martín, Miguel ^a   Maestro, María Luisa ^a   Vidaurreta, Marta ^a   Veganzones, Silvia ^a   Rafael, Sara ^a   Casado, Antonio ^a   Bobokova, Jana ^a   Sastre, Javier ^a   De La Orden, Virginia ^a   Arroyo, Manuel ^a   Eduardo Diaz Rubio ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Circulating tumour cells (CTCs); Locally advanced breast cancer (LABC)

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; COHORT ANALYSIS; FEMALE; HUMAN; PATHOLOGY; PROSPECTIVE STUDY; TUMOR EMBOLISM;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; NEOADJUVANT THERAPY; NEOPLASTIC CELLS, CIRCULATING; PROSPECTIVE STUDIES;

EID: 74049120222     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-009-0400-4     Document Type: Article

References (16)

1. Simpson JF, Gray R, Dressler LG et al (2000) Prognostic value of histological grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol 18:2059-2069
2. Cristofanilli M (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791
3. Braun S, Naume B (2005) Circulating and disseminated tumor cells. J Clin Oncol 23:1623-1626
4. Riethdorf S, Fritsche H, Müller V et al (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin Cancer Res 13:920-928
5. Tewes M, Aktas B, Welt A et al (2008) Molecular profi ling and predictive value of circulating tumor cells in patients with metastatic breast cancer: An option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat 115:581-590
6. Dawood S, Broglio K, Valero V et al (2008) Circulating tumor cells in metastatic breast cancer: From prognostic stratification to modification of the staging system? Cancer 113:2422-2430
7. Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10:6897-6904
8. Symmans WF, Peintinger F, Hatzis C et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25:4414-4422
9. Di Leo A, Claudino W, Colangiuli D et al (2007) New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer. Ann Oncol 18[Suppl]:xii8-14
10. Cristofanilli M, Broglio KR, Guarneri V et al (2007) Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden. Clin Breast Cancer 7:471-479
11. Nolé F, Munzone E, Zorzino L et al (2008) Variation of circulating tumor cell levels during treatment of metastatic breast cancer: Prognostic and therapeutic implications. Ann Oncol 19:891-897
12. Ghossein RA (1999) Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5:1950-1960
13. Iakovlev VV, Goswami RS, Vecchiarelli J et al (2008) Quantitative detection of circulating epithelial cells by Q-RT-PCR. Breast Cancer Res Treat 107:145-154
14. Molloy TJ, Bosma AJ, Van't Veer LJ (2008) Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells. Breast Cancer Res Treat 112:297-307
15. Hayes DF, Smerage J (2008) Is there a role for circulating tumor cells in the management of breast cancer? Clin Cancer Res 14:3646-3650
16. Lang JE, Mosalpuria K, Cristofanilli M (2008) HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res Treat 113:501-507